Financial Analyzer can assist you in cost and profit comparisons of various bone densitometry systems. For example, the cost of installing a QCT bone densitometry system for use with an existing CT installation will typically be dominated by the capital expenditure for the QCT package. In contrast, a DXA system may involve significant expenses for system siting and personnel to operate the DXA scanner. Differences in operational costs due to, for example, differences in the time to perform a bone density study using 2 different QCT packages can also be modeled.

Financial Analyzer assists you in estimating the patient referral rate you need to achieve your financial goals. Patient referral rate is, perhaps, the least well known of the many input parameters you may define. Estimates by the NOF indicate that only about 10% of women at risk for osteoporosis in a typical community are currently being screened for low bone density--the single most important risk factor for osteoporosis. Increasing awareness in the need for osteoporosis screening and the International Society of Clinical Densitometry recommendation that patients screened by hand, arm or heel methods and found to have low bone density be referred for a central BMD measurement (QCT or DXA) suggest that the referring population for QCT will increase substantially in coming years. Evaluating your patient referral base may be one of the best ways to estimate the long-term potential return on your investment.

We hope that you find Financial Analyzer useful and that it provides you with yet another reason for purchasing a QCT bone densitometry system from Mindways.